Clinical Nephrology – Epidemiology – Clinical Trials

Kidney International (2002) 62, 2223–2229; doi:10.1046/j.1523-1755.2002.00683.x

Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure

Christos P Carvounis, Sabeeha Nisar and Samerah Guro-Razuman

Department of Medicine, Division of Nephrology, Nassau University Medical Center and State University of New York at Stony Brook, East Meadow, New York, USA

Correspondence: Christos P. Carvounis M.D., MACP, FCCP, FACN, Academic Affairs, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, New York 11554, USA. E-mail: christos@ncmc.edu

Received 5 July 2001; Revised 23 July 2002; Accepted 25 July 2002.

Top

Abstract

Significance of the fractional excretion of urea in the differential diagnosis of acute renal failure.

Background

 

Fractional excretion of sodium (FENa) has been used in the diagnosis of acute renal failure (ARF) to distinguish between the two main causes of ARF, prerenal state and acute tubular necrosis (ATN). However, many patients with prerenal disorders receive diuretics, which decrease sodium reabsorption and thus increase FENa. In contrast, the fractional excretion of urea nitrogen (FEUN) is primarily dependent on passive forces and is therefore less influenced by diuretic therapy.

Methods

 

To test the hypothesis that FEUN might be more useful in evaluating ARF, we prospectively compared FEUN with FENa during 102 episodes of ARF due to either prerenal azotemia or ATN.

Results

 

Patients were divided into three groups: those with prerenal azotemia (N = 50), those with prerenal azotemia treated with diuretics (N = 27), and those with ATN (N = 25). FENa was low only in the patients with untreated plain prerenal azotemia while it was high in both the prerenal with diuretics and the ATN groups. FEUN was essentially identical in the two pre-renal groups (27.9 plusminus 2.4% vs. 24.5 plusminus 2.3%), and very different from the FEUN found in ATN (58.6 plusminus 3.6%, P < 0.0001). While 92% of the patients with prerenal azotemia had a FENa <1%, only 48% of those patients with prerenal and diuretic therapy had such a low FENa. By contrast 89% of this latter group had a FEUN <35%.

Conclusions

 

Low FEUN (less than or equal to35%) was found to be a more sensitive and specific index than FENa in differentiating between ARF due to prerenal azotemia and that due to ATN, especially if diuretics have been administered.

Keywords:

fractional excretion of sodium, acute tubular necrosis, prerenal ARF, diuretic therapy, azotemia, intensive care

Identifying the cause of acute renal failure is a common problem in clinical practice. The fractional excretion of filtered sodium (FENa) has been shown to discriminate reliably between prerenal azotemia and acute tubular necrosis (ATN)1,2,3,4. However, there are several reports of low FENa (less than 1%) in conditions associated with intrinsic acute renal failure, such as sepsis, contrast nephropathy, myoglobulinuria and nonoliguric ATN1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17. Furthermore, a common major limitation in the use of FENa stems from the fact that diuretic agents are employed frequently in the treatment of prerenal conditions such as congestive heart failure, liver failure with ascites, or to enhance urine output in oliguric patients. In addition, the excessive use of diuretics in a formerly euvolemic subject may lead to a prerenal state, often with increased urinary Na and thus increased FENa. Other situations also exist where prerenal azotemia is associated with increased urinary sodium and increased FENa. Most prominent among them is volume depletion and prerenal azotemia due to vomiting or nasogastric suction. In such cases the ensuing bicarbonaturia maintains urinary sodium and FENa at high levels18. In an attempt to find a more useful guide, we evaluated the fractional excretion of urea nitrogen (FEUN). We demonstrate that FEUN is at least as sensitive and specific as FENa in the usual prerenal cases and, in contrast to the latter, does not lose its sensitivity or specificity in diagnosing prerenal azotemia in the presence of diuretic therapy.

Top

METHODS

This was a prospective, Institutional Review Board approved study that took place at Nassau County Medical Center, a large (612 beds) public hospital. One hundred two consecutive adult patients referred to the Nephrology service (mostly from the Intensive Care Units) for evaluation of acute renal failure, comprised the subjects of this study. The major reason for consultation was a rapidly increasing blood urea nitrogen (BUN) and creatinine (BUN>30 mg/dL and creatinine>1.5 mg/dL) with or without oliguria. Urine output measurements were available for most patients, in particular all the ATN patients who were typically found in one of the ICUs, all of whom had Foley catheters. In all cases, the diagnosis was made by the consulting attending nephrologist, based on the medical history, physical examination, and evaluation of urine sediment morphology and composition, as suggested by standard textbooks1, and is shown in Table 1. The members of the renal service used the usual urinary indices as described in Table 1. Urinary urea nitrogen was not available at the time of consultation, but was measured later in batches of urine specimens from 5 to 10 patients. Twenty-seven of the patients had received diuretic therapy (furosemide or thiazides, up to the day of consultation). Patients with acute interstitial nephritis, acute glomerulonephritis, and obstructive nephropathy were not included in the present study as there were a small number of patients in each category (3, 1, and 1, respectively) that would not allow for drawing any meaningful conclusions.


Prerenal azotemia was the result of circulatory failure secondary to various causes such as sepsis, gastrointestinal bleeding, hepatic, respiratory or cardiac failure. The diagnosis of prerenal azotemia was established in circulatory failure when improvement of heart function, cessation of diuretic therapy, or treatment of shock effected a prompt increase in urinary output and creatinine clearance. Of the 50 cases of prerenal azotemia, 16 had sepsis, 10 congestive heart failure, 7 hepatic failure and 7 gastrointestinal bleeding. The remaining patients had miscellaneous or less definite diagnoses. Twenty-four were men and 26 were women, with an average age of 49 plusminus 2 years (mean plusminus SEM). The demographics were actually quite similar in all subgroups where the representation of men to women were 14 to 13 in the group of prerenal on diuretics and 13 to 12 in the ATN group. The mean ages were 51 plusminus 3 and 47 plusminus 3 in these two groups, respectively.

As expected, the majority of the prerenal cases receiving diuretics were subjects with congestive heart failure. Acute tubular necrosis (ATN) resulted from nephrotoxic drugs (aminoglycoside antibiotics), myoglobinuria, sustained circulatory failure, or massive surgical volume losses unresponsive to replacement. Thirteen patients had protracted sepsis, although the exact role of coexistent factors such as major surgical procedures (8 of these) or use of nephrotoxins (5 were on aminoglycoside therapy) does not allow for a clear-cut identification of the underlying etiology. Myoglobinuria caused six cases of ATN (3 due to cocaine, 1 due to alcohol, 1 due to phosphorus depletion and 1 due to trauma). The remainder of the cases had a mixed and often less well identified etiology.

The indices evaluated at the time of consultation were urinary sodium (UNa), urinary sodium/potassium ratio (UNa/K; a reflection of prerenal conditions with associated hyperaldosteronism), urinary to plasma creatinine ratio (U/PCr), and fractional excretion of sodium (FENa). Fractional excretion of urea (FEUN) was determined later. The FENa was calculated as [(urine sodium/ plasma sodium)/(urine creatinine/plasma creatinine)]times 100. The FEUN was calculated as: [(urine urea nitrogen/ blood urea nitrogen)/(urine creatinine/plasma creatinine)]times 100. In well-hydrated individuals, the FEUN is 50 to 65%19. In the presence of oliguria and prerenal azotemia, FEUN less than or equal to 35% with progressive decline has been found as urine volume decreases to about 0.5 mL/min or less19. Indeed, as urine volume decreases to oliguric levels (<0.35 mL/min or 500 mL/day) FEUN decreases proportionally to urine flow20. For that reason, we selected a FEUN value of 35% to signify prerenal azotemia. On the other hand, in intrinsic renal failure the clearance of urea decreases to an equal degree or less than the clearance of creatinine. Thus, an FEUN more than 50% indicates acute tubular necrosis. Blood chemistries were performed on a Beckman automated analyzer for serum electrolytes, creatinine and urea (Beckman Instruments, Fullerton, CA, USA). Urine electrolytes were determined by flame photometry. Urine urea nitrogen and creatinine were determined spectrophotometrically on spot urine samples collected at the bedside. In one part of the study the measured FEUN (as described earlier in this article) was compared with the expected FEUN from the study of Dole, where FEUN = 0.57 e-(0.36/V)19. In a few prerenal cases where accurate Vdot (urine flow in mL/min) was difficult to assess, the Vdot calculated from U/PCr was used with Vdot = 100/(U/PCr) as described previously by Homer Smith21.

Statistical analysis was performed using the appropriate statistical method22. One way analysis of variance (ANOVA) was used when more than two groups were evaluated. Comparison among the groups was tested using the Bonferroni-corrected t test. In paired experiments between two groups, the paired Student t test was used. Linear regression was calculated by using the least squares method and the Pearson product moment analysis. All tests were performed using Sigma Stat®, a statistical software program of the Jandel Corporation (Corte Madera, CA, USA). In tests presented in nominal (categorical) form, we determined the sensitivity, the specificity, the positive predictive value, and the negative predictive value. These tests also were compared by using the receiver operated characteristic (ROC) curves22.

Top

RESULTS

The patients were divided into three groups. The first group was composed of 50 patients with prerenal failure, the second group had 27 patients with prerenal azotemia but also given diuretics (furosemide), and the third group had 25 patients with established ATN. The indices evaluated in ARF are shown in Table 2. It is clear that while FENa was characteristically low (<1%) in the prerenal group, it was substantially higher than 1% in both the prerenal group given diuretics and the ATN group. In contrast, the increased BUN/creatinine ratio, the urine-to-plasma creatinine ratio (U/PCr) and, more impressively, the FEUN, were consistently different in both prerenal groups from those in the ATN group Figure 1. Indeed, the FEUN was essentially identical in the two prerenal groups (27.9 plusminus 2.4% vs. 24.5 plusminus 2.3%), significantly different from the FEUN found in ATN (58.6 plusminus 3.6%, P < 0.0001).

Figure 1.
Figure 1 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Levels of blood urea nitrogen/creatinine (BUN/Cr; A), fractional excretion of sodium (FENa; B), fractional excretion of urea nitrogen (FEUN; C), and urinary plasma to creatinine ratio (U/PCr; D) are schematically represented for each category of acute renal failure. BUN/Cr and U/PCr are ratios and have no units. FENa and FEUN are expressed as %. Please note that FEUN is similar among prerenal patients, irrespective of their use or non-use of diuretics. Note a rather substantial variability with other indices.

Full figure and legend (64K)


Table 3 and Figure 2 show the importance of the indices in patients in whom a given test was positive. It appears that FENa, FEUN, and U/PCr are the indices that discriminate best among the different types of acute renal failure. While 92% of the patients with prerenal azotemia had a FENa <1%, only 48% of patients who were prerenal and on diuretic therapy had a low FENa. By contrast, 89% of this latter group had a FEUN <35%. If one combines all the prerenal cases, FEUN had the best sensitivity and specificity (90 and 96%, respectively), and the best positive and negative predictive value (99 and 75%, respectively) of all the indices examined in this study.

Figure 2.
Figure 2 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Sensitivity of the three major indices for patients with prerenal situations with or without diuretic use, and patients with ATN. The units shown on the vertical axis represent %. Please note that while all three indices are equally effective in patients with prerenal situations who did not use diuretic therapy, only FEUN retains its high sensitivity even in prerenal patients who use diuretics. Symbols are: (Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author) FENa; (filled square) FEUN; (square) U/PCr.

Full figure and legend (37K)


Table 4 evaluates the positivity of different levels of the three most important indices in patients with acute renal failure. Again, when examining the combined prerenal group compared with that of ATN, FEUN was the best discriminatory index. For instance, a FENa of less than 1% was present in 77% of prerenal patients and in about 4% of patients with ATN, while FEUN <35% was found in 90% of prerenal patients and again in 4% of patients with ATN. U/PCr appears to be an intermediate differentiator. When a ratio higher than 15 was used as the cutoff value, 90% of patients with prerenal azotemia were positive, with only a small number of patients with ATN having such a level (8%). Figures 3 and 4 show the ROC curves for these data.

Figure 3.
Figure 3 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Sensitivity and false positivity of different cut of levels are plotted for FENa (diamond) and U/PCr (filled diamond). The levels used are the same that are shown for the two parameters in Table 3. Sensitivity was defined by the % of patients who were positive for prerenal (either with or without diuretics) at a given level of each test. False positive was defined as the % of patients with ATN who had pre-renal values for any level.

Full figure and legend (19K)

Figure 4.
Figure 4 - Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Sensitivity and false positivity of different cut of levels are plotted for FEUN (filled diamond) and FENa (diamond). The levels used are the same that are shown for the two parameters in Table 3. Sensitivity was defined as the % of patients who were positive for prerenal (either with or without diuretics) at a given level. False positive was defined as the % of patients with ATN who had prerenal values for any level. While the area under FEUN is 97.2%, that under FENa is significantly less (88.9%).

Full figure and legend (22K)


We evaluated the equations that describe the relationship between the FEUN and U/PCr in our subjects. This was based on previous findings regarding such a relationship (see discussion below for details). We found major differences among the different groups. In prerenal azotemia, FEUN = 27.9–0.029 (U/Pcr), r = 0.28, P = 0.015, and was similar for the two groups of prerenal patients (prerenal alone or prerenal in the presence of diuretic therapy). In patients with ATN a very different relationship was noted: FEUN = 70.3–1.26 (U/PCr), r = 0.439, P = 0.028, consistent with very different mechanisms of the generation of such a relationship.

Finally, the predicted FEUN was examined using Dole's equation as described in the Methods section. In the prerenal patients, the expected FEUN was 25 plusminus 4% and 22 plusminus 4% for the prerenal group without and with diuretic use, respectively. These values were not statistically different from the ones actually found (27 plusminus 2% and 24 plusminus 3%, respectively), suggesting that indeed the mechanism for the decreased volume (decreased renal perfusion and increased water reabsorption) also was responsible for the decreased excretion of urea. In contrast, in the cases of ATN the calculated FEUN was very different from the one actually determined (18 plusminus 3% vs. 58 plusminus 6%, P < 0.0001), suggesting that the oliguria found in this condition is not related to reabsorption of water and urea from functional tubules, but rather due to minimal glomerular filtration through injured nephrons.

Top

DISCUSSION

When urine excretion decreases as a result of water reabsorption, the level of urinary creatinine increases in inverse proportion to the volume of urine output. Thus, the U/P creatinine ratio logically identifies whether oliguria is the result of increased water reabsorption, as in the case of prerenal situations (U/PCr>20) or is due to the loss of nephron function (U/PCr <20)21. As is often appreciated, sodium reabsorption also increases in prerenal states both as a result of an increase in aldosterone as well as the increased sodium and water reabsorption in the proximal tubule because of the increased filtration fraction found in such cases. A composite index has been developed and used clinically that incorporates both U/PCr and UNa, the FENa. Following the initial report of Espinel4, which showed that FENa discriminates best between the two most commonly encountered forms of ARF (prerenal and ATN), several subsequent reports substantiated this claim1,2,3,4. Currently it has become the dominant discriminatory index used for that purpose. On the other hand, coexistence of a prerenal state and natriuretic agents (diuretics) negate the effectiveness of this index1. Diuretics represent the mainstay of treatment for several prerenal states and may themselves produce volume depletion due to their natriuretic effect (even if given to initially euvolemic patients). Furthermore, these agents are used commonly in the hospital and even more in the intensive care unit, thus significantly decreasing the utility of FENa in the hospital setting. Hence, FENa does not give a clear-cut distinction in such cases. In addition to the use of diuretics, other situations are known to lead to both prerenal azotemia and increased FENa. Better understood among them is the case of volume depletion due to vomiting or naso-gastric suction associated with increased FENa due to bicarbonaturia18. On the other hand, a number of clear-cut forms of ATN are associated with decreased FENa, for example: myoglobinuria6,7, sepsis8, contrast nephropathy11,12,13, obstructive uropathy15, and non-oliguric ATN2,3,5. Low FENa also is found in other forms of acute intrinsic renal failure including acute glomerulonephritis2,3, urinary tract obstruction2, and renal allograft rejection2. To emphasize the frequency with which patients with intrinsic acute renal failure have FENa <1%, suffice it to say that in a five year-period (1980 to 1985) more than 100 cases of documented ATN with FENa <1% were found in the published literature alone17.

The relative clearance of urea denoted by the FEUN is affected by decreased renal perfusion as seen in prerenal states. As early as 1921, Austin, Stillman and Van Slyke showed that the clearance of urea in man decreases substantially in dehydration somewhat proportionally to urine output23. In 1938, two seminal studies established that FEUN relates inversely to U/P creatinine24 and U/P inulin25,26, and therefore proportionally to urine volume. This was the classical teaching in renal physiology during that era27,28. More recently, Goldstein, Lenz and Levitt evaluated the relationship of urine volume to urea excretion in humans29. Using proximal and distal diuretic agents, they found that the percent of filtered urea excreted increased with proximal (mannitol and acetazolamide) but not with distal agents (mercaptomerin and ethacrynic acid). This suggests that urea is not reabsorbed significantly in the distal nephron. Given that most of the diuretics used clinically work at distal sites, FEUN should not be affected by their use. This is in contrast to FENa, which is increased by all forms of diuretics. Only in patients with established chronic renal failure does the use of diuretics and the ensuing volume depletion also operate in distal sites30, a finding with limited significance in the differential diagnosis of ARF.

In 1992, Kaplan and Kohn reported six prerenal patients with a discrepancy of FEUN and FENa in the presence of diuretics31. In addition to the small number, most of those patients already had established renal failure, congestive heart failure and various treatments with angiotensin-converting enzyme inhibitors. The authors, in order to better understand the situation, retrospectively evaluated the charts of 87 patients with prerenal azotemia. They noted that the patients that had both low FENa and FEUN had the usual type of prerenal azotemia. The group with low FEUN but high FENa appeared to have prerenal azotemia but had been treated with a diuretic (39 out of 40). The authors concluded that FEUN may be a better index to evaluate possible prerenal status in patients who receive diuretic agents.

We prospectively studied three groups of patients: patients with prerenal azotemia, patients with prerenal conditions receiving diuretics, and patients with acute tubular necrosis (ATN). We found that FENa failed to discriminate between prerenal patients given diuretics and those with ATN. FEUN, on the other hand, was excellent in discriminating among all cases of prerenal azotemia and ATN irrespective of the use of diuretics. This has a potentially major practical application, given the frequency of diuretic use in the hospital setting. For instance, among our 77 unselected prerenal cases, 27 (35%) had been given diuretics.

Our study found that U/PCr is higher in prerenal cases, as has been shown before and as expected from the underlying physiology. Indeed, it appears that U/PCr is at least as good as FENa in separating prerenal azotemia from ATN. As was previously reported24,25,26,27,28, there was a close inverse relationship between U/PCr and FEUN in the prerenal group. This relationship was very different in the group with ATN. Furthermore, the prerenal patients appear to follow the prediction of Dole19 in reference to expected FEUN based on urine output. In short, these patients behaved the same way as a normal individual with decreased fluid intake and thus decreased urine output. In contrast, urine volume could not account for the FEUN found in the ATN group.

We found that FEUN has a high sensitivity (85%) a high specificity (92%) and more importantly a high positive predictive value (98%). The latter suggests that if a FEUN of <35% is found, 98% of such cases will have prerenal azotemia. The relative importance of FEUN to FENa would have been more impressive if our ATN patients had had some of the characteristics described in the literature. For example, low FENa is often found in patients with myoglobinuric ATN6,7; however, in our study none of the six patients with well-documented myoglobinuria (history and urine analysis positive for myoglobin) had an FENa value less than 1. If the value had been greater, then the false-positive cases of low FENa in identifying pre-renal azotemia would have been even higher.

Fractional excretion of urea nitrogen to a great extent relates inversely to the proximal reabsorption of water. Proximal reabsorption of water (accompanied by urea) increases when renal perfusion decreases and filtration fraction increases. Thus, urea reabsorption leads to a decrease in FEUN and an increase in the BUN/creatinine ratio. The use of indices that reflect proximal tubular function in acute renal failure have been suggested before. A recent textbook of nephrology suggests two such indices, the clearance of lithium and the clearance of uric acid32. It is apparent that the use of lithium clearance is quite impractical, given the limited availability of this determination in many laboratories and the need to administer lithium to such patients. Uric acid clearance does not appear to have any advantage over the use of urea, due to its rather complex renal metabolism.

It is certainly interesting, that if we modify the formula for FEUN = (U/P)UN/(U/P)Cr, it becomes FEUN = U dot (UN/Cr)/(BUN/Cr), or even, BUN/Cr = U (UN/Cr)/FEUN. This suggests that as proximal urea reabsorption increases and FEUN decreases in prerenal states, the BUN/Cr ratio increases, as is the common teaching and is our own experience in the present study Table 2. Another cause of increased BUN/Cr is increased urea production (and thus excretion), as in cases of hypercatabolism or consumption of high protein diets. This could be easily differentiated from prerenal azotemia, as in high urea production we have a high urine UN/Cr, much higher than the usual ratio of 5 to 10. The determination of urine urea nitrogen and FEUN may be helpful in a few other conditions. For instance, the presence of a BUN/Cr ratio of 10 in the presence of a low UUN/UCr (<5) suggests the existence of prerenal azotemia in a starving individual.

There are situations, however, where FEUN may fail to indicate the ongoing prerenal status. Therefore, such possibilities should be kept in mind when FEUN is used. For instance, in osmotic diuresis the proximal tubular absorption of salt and water is impaired and thus increased FEUN is expected despite renal hypoperfusion. One of us (C.P.C.) has looked into this while working on another study (abstract; Vafadouste R et al, XV International Congress of Nephrology, Buenos Aires, Argentina, p 1999, 2001). In ten patients with osmotic diuresis there was a mild increase of BUN (23 plusminus 3.3 mg/dL) with normal serum creatinine (0.9 plusminus 0.1 mg/dL), increased BUN/Cr to 27 plusminus 3, increased FEUN 49 plusminus 8%, high normal FENa 0.7 plusminus 0.3% and high U/PCr of 41 plusminus 10. The same phenomenon is expected to happen when osmotic diuretics such as acetazolamide and mannitol are used. Indeed, this was our finding during that study. Similar findings also were reported before29. A similar picture emerges in patients given a high protein diet or having excessive catabolism. There, the enormous production of urea acts as the osmotic diuretic agent. On the other hand, FEUN could be helpful in cases with prerenal azotemia in combination with a distal defect in sodium reabsorption. We recently encountered a young male with AIDS and Addison's disease. He had apparent volume depletion with dramatic changes in blood pressure and pulse rate with even the mildest tilting maneuvers. His BUN/Cr was high (84/2.3), and he had a high FENa (>2%), a FEUN of 35% and a U/PCr of 27. This patient responded promptly to vigorous saline infusion, indicating that his major problem was that of volume depletion in the presence of impaired distal tubular Na+ reabsorption.

Although FEUN proved to be the best index under the clinical conditions encountered in our study, one must remember that none of the indices offers a 100% discriminatory ability. The three major indices allow evaluation of different sites of action, and differ in the technology needed for their determination, thus making it unlikely to have simultaneous laboratory errors in all of them. FEUN allows insight to proximal peritubular forces, FENa mostly reflects distal forces (mostly aldosterone-dependent sites), and U/PCr indicates water reabsorption through the length of the nephron. Indices are tools and do not obviate the importance of history, physical examination, and direct urinalysis in making a diagnosis of acute renal failure.

Top

References

REFERENCES

  1. Brady, HR, Brenner, BM, Lieberthal, W: Acute renal failure, in Brenner & Rector's The Kidney (1996, 5th ed), edited by Brenner BM, Philadelphia, W.B. Saunders, pp 1200–1252
  2. Zarich, S, Fang, LS, Diamond, JR: Fractional excretion of sodium. Exceptions to its diagnostic value. Arch Int Med 1985 145: 108–112,  | ISI | ChemPort |
  3. Miller, TR, Anderson, RJ, Linas, SL, et al: Urinary diagnostic indices in acute renal failure. Ann Intern Med 1978 89: 47–50,  | PubMed | ISI | ChemPort |
  4. Espinel, CH: The FENa test: Use in the differential diagnosis of acute renal failure. JAMA 1976 236: 579–581,  | Article | PubMed | ISI | ChemPort |
  5. Danovitch, G, Carvounis, C, Weinstein, E, Levenson, S: Non-oliguric acute renal failure. Isr J Med Sci 1979 15: 5–8,  | PubMed | ISI | ChemPort |
  6. Steiner, RW: Low fractional excretion of sodium in myoglobinuric acute renal failure. Arch Intern Med 1982 142: 1216–1217,  | ISI |
  7. Corwin, HL, Schreiber, MJ, Fang, ST: Low fractional excretion of sodium. Occurrence with hemoglobinuric and myoglobinuric acute renal failure. Arch Intern Med 1984 144: 981–982,  | Article | PubMed | ISI | ChemPort |
  8. Vaz, AJ: Low fractional excretion of urine sodium in acute renal failure due to sepsis. Arch Intern Med 1983 143: 738–739,  | Article | PubMed | ISI | ChemPort |
  9. Pru, C, Kjellstrand, CM: On the clinical usefulness of the FENa test in acute renal failure: A critical analysis. Proc Dial Transplant Forum 1980 10: 240–246,  | ChemPort |
  10. Pru, C, Kjellstrand, CM: The FENa test is of no prognostic value in acute renal failure. Nephron 1984 36: 20–23,  | PubMed | ISI | ChemPort |
  11. Fang, LST, Sirota, RA, Ebert, TH, et al: Low fractional excretion of sodium with contrast media-induced acute renal failure. Arch Intern Med 1980 140: 531–533,  | Article | PubMed | ISI | ChemPort |
  12. Carvallo, A, Raboski, TA, Argy, WP, et al: Acute renal failure following drip infusion pyelography. Am J Med 1978 65: 38–45,  | Article | PubMed | ISI | ChemPort |
  13. VanZee, B, Hoy, W, Talley, TE, et al: Renal injury associated with intravenous pyelography in non-diabetic and diabetic patients. Ann Intern Med 1978 89: 51–54,  | PubMed | ISI | ChemPort |
  14. Oken, DE: On the differential diagnosis of acute renal failure. Am J Med 1981 71: 916–920,  | Article | PubMed | ISI | ChemPort |
  15. Hoffman, LM, Suki, WN: Obstructive uropathy mimicking volume depletion. JAMA 1976 236: 2096–2097,  | Article | PubMed | ISI | ChemPort |
  16. Steiner, RW: Interpreting the fractional excretion of sodium. Am J Med 1984 77: 699–702,  | Article | PubMed | ISI | ChemPort |
  17. Pru, C, Kjellstrand, CM: Urinary indices and chemistries in the differential diagnosis of prerenal failure and acute tubular necrosis. Semin Nephrol 1985 5: 224–233,  | PubMed | ISI | ChemPort |
  18. Nanji, AJ: Increased fractional excretion of sodium in prerenal azotemia: Need for careful interpretation. Clin Chem 1981 27: 1314–1315,  | PubMed | ISI | ChemPort |
  19. Dole, VP: Back diffusion of urea in the mammalian kidney. Am J Physiol 1943 139: 504–519,  | ChemPort |
  20. Chesley, LC: Urea excretion at low urine volumes. The calculation of 'minimal' urea clearances. J Clin Invest 1938 17: 119–138,  | ChemPort |
  21. Smith, HW: Principles of Renal Physiology. 1956, New York, Oxford University Press, pp 79–81
  22. Carvounis, CP: Medical Statistics. 2000 London, Parthenon Publishing Group, Inc.,
  23. Austin, JH, Stillman, E, Van Slyke, DD: Factors governing the excretion of urea. J Biol Chem 1921 46: 91–102,  | ChemPort |
  24. Chasis, H, Smith, HW: The excretion of urea in normal man and in subjects with glomerulonephritis. J Clin Invest 1938 17: 347–358,  | ChemPort |
  25. Bull, GM, Joekes, AM, Lowe, KG: Renal function studies in acute tubular necrosis. Clin Sci 1950 9: 379–404,  | ISI |
  26. Shannon, JA: The renal reabsorption and excretion of urea under conditions of extreme diuresis. Am J Physiol 1938 123: 182–196,
  27. Smith, HW: The Kidney. Structure and function in health and disease. 1951, New York, Oxford University Press, pp 63–80
  28. Pitts, RF: Kidney and Body Fluids (1968, 2nd ed). Chicago, Year Book Medical Publishers Inc., pp 88–93
  29. Goldstein, MH, Lenz, PR, Levitt, MF: Effect of urine flow rate on urea reabsorption in man. Urea as a 'tubular marker'. J Appl Physiol 1969 26: 594–599,  | PubMed | ISI | ChemPort |
  30. Dal Canton, A, Fuiano, G, Conte, G, et al: Mechanism of increased plasma urea after diuretic therapy in uremic patients. Clin Sci 1985 68: 255–261,  | PubMed | ChemPort |
  31. Kaplan, AA, Kohn, OF: Fractional excretion of urea as a guide to renal dysfunction. Am J Nephrol 1992 12: 49–54,  | PubMed | ISI | ChemPort |
  32. Dwinnell, BG, Anderson, RJ: Diagnostic evaluation of the patient with acute renal failure, in Atlas of Diseases of Kidney, 1999, edited by Schrier RW, Philadelphia, Current Medicine Inc., pp 12.1–12.12
Top

Acknowledgments

This study was presented in part in the 33rd Annual Scientific Meetings of the American Society of Nephrology in Toronto, Canada, on October 13, 2000. The authors acknowledge their gratitude to Drs. Donald A. Feinfeld, Thomas Manis, and Laurie Ward for their critical evaluation of this manuscript and their many suggestions during the study

Extra navigation

.
ADVERTISEMENT